RegistryReach
← The Provider Money Map / Endocrinology, Diabetes & Metabolism

Drug & device makers paid Endocrinology, Diabetes & Metabolism providers $38.8M in 2025.

Every manufacturer payment to a provider is public record under the Sunshine Act. Here's the 2025 picture for Endocrinology, Diabetes & Metabolism from the federal Open Payments database: who writes the checks, and where the money lands.

2025 payments
$38.8M
Providers paid
5,667
Avg per provider
$7K
vs 2024
▲ 21%

Who's writing the checks

Top manufacturers paying Endocrinology, Diabetes & Metabolism providers in 2025.
Lilly USA, LLC
$7.9M
Novo Nordisk Inc
$7.7M
Corcept Therapeutics
$2.5M
Amgen Inc.
$2.4M
Ascendis Pharma Endocrinology Inc
$1.7M
Abbott Laboratories
$1.7M
SANOFI-AVENTIS U.S. LLC
$1.3M
Dexcom, Inc.
$1.1M

Where the money lands

Top states by 2025 payment total. Tap a state for its full picture.
$6.0M
$3.4M
$1.4M
Want the names behind these numbers?
Build a list of Endocrinology, Diabetes & Metabolism providers in any state, ranked by what industry actually paid them, with verified practice contact details. Preview counts free.
Build a Endocrinology, Diabetes & Metabolism list →